Severe nocturnal hypoglycaemia (n/N) Definition: severe hypoglycaemia occurring from 22:00 to 06:59 h
Summary of findings: insulin degludec showed no clear difference in severe nocturnal hypoglycaemia (n/N) Definition: severe… compared with insulin glargine (low certainty).
1 finding from 1 review
Serious adverse events (n/N)
Summary of findings: insulin degludec showed no clear difference in serious adverse events (n/N) compared with insulin glargine (low certainty).
1 finding from 1 review
HbA1c (%)
1 finding from 1 review
Health‐related quality of life Scales: Well‐Being Enquiry for Diabetics; General Well‐being; Diabetes Quality of Life for Youth and Parents' Diabetes Quality of Life
1 finding from 1 review
Macrosomia · pregnant women with pre‐existing diabetes
1 finding from 1 review
Perinatal mortality · pregnant women with pre‐existing diabetes
1 finding from 1 review
Pre‐eclampsia · pregnant women with pre‐existing diabetes
1 finding from 1 review
Caesarean section · pregnant women with pre‐existing diabetes
1 finding from 1 review
Fetal anomaly (major) · pregnant women with pre‐existing diabetes
It is very uncertain whether insulin Detemir + prandial insulin Aspart changes fetal anomaly (major) compared with NPH insulin + prandial insulin Aspart (Different insulin types… (very low certainty).
1 finding from 1 review
Birth trauma including shoulder dystocia, nerve palsy, or fracture · pregnant women with pre‐existing diabetes
1 finding from 1 review
Composite outcome measure of neonatal morbidity · pregnant women with pre‐existing diabetes
1 finding from 1 review
Hypoglycaemic episodes a) Non‐serious hypoglycaemia
It is very uncertain whether insulin analogues changes hypoglycaemic episodes a) Non‐serious hypoglycaemia compared with biphasic insulin (very low certainty).
1 finding from 1 review
Health‐related quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events other than hypoglycaemia
It is very uncertain whether insulin analogues changes any adverse events other than hypoglycaemia compared with biphasic insulin (very low certainty).
1 finding from 1 review
All‐cause mortality
It is very uncertain whether insulin analogues changes all‐cause mortality compared with biphasic insulin (very low certainty).
1 finding from 1 review
Treatment satisfaction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HbA1c (%)
1 finding from 1 review
Transplant or graft survival · pre‐existing and new‐onset diabetes in kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Delayed graft function · pre‐existing and new‐onset diabetes in kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HbA1c (%) · pre‐existing and new‐onset diabetes in kidney transplant recipients
1 finding from 1 review